| Name | Title | Contact Details |
|---|
IHP offers health plan options to companies across the country, with the goal of providing affordable healthcare with a clear, and distinct, schedule of benefits. Our plans are guaranteed issue, zero deductible, and co-pay driven—well change the way you think about healthcare.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Johnson & Johnson is a multinational healthcare company founded in 1886 in New Brunswick, New Jersey. The company is dedicated to improving human health and well-being through its innovative products and services. Johnson & Johnson operates in three main segments. The Consumer Health segment includes popular brands like Band-Aids, Tylenol, and Johnsons baby products, offering a variety of personal care and over-the-counter medications. The Pharmaceuticals division develops prescription drugs across therapeutic areas such as immunology, infectious diseases, and oncology. Lastly, the Medical Devices segment focuses on creating and manufacturing devices and diagnostics for surgical procedures, orthopedics, and vision care. The companys products cater to a wide audience, including consumers, healthcare professionals, and medical institutions, ensuring accessibility and support for various health needs.
Smardt Chiller Group is a global leader in oil-free centrifugal chiller technology, focusing on high-efficiency HVAC solutions for commercial, industrial, and institutional applications. Founded in 2005 by Roger Richmond-Smith and Ron Conry, the company has over 25 years of experience in magnetic bearing compressors and oil-free systems. Smardt operates manufacturing facilities in Canada, the USA, Australia, Germany, and China, with more than 10,000 chillers installed worldwide. The company offers a range of products, including water-cooled, air-cooled, and evaporative-cooled chillers, as well as customizable modular systems. All chillers utilize oil-free centrifugal compressors with magnetic bearings, which enhance energy efficiency and reduce maintenance needs. Smardt also provides custom engineering, global support for installation and maintenance, and energy efficiency consulting to help clients optimize their systems and reduce carbon footprints. The company serves various industries, including government facilities, pharmaceutical manufacturing, data centers, and hospitals, emphasizing reliability and sustainability in its solutions.